Menu

Amryt Pharma plc AMYT

Full chart Compare
Set alert

Price alert · AMYT

All alert types
14.70 +14.70

Day range unavailable

52-week range unavailable

Revenue & Expenses

Other Income → Gross Profit & Other Income: $59.93MGross Profit & Other Income → Net Income: $1.00MGross Profit & Other Income → Selling, General & Admin: $92.00MGross Profit & Other Income → Research & Development: $37.73MGross Profit & Other Income → Other Operating Expenses: $25.29MGross Profit & Other Income → Interest Expense: $27.91MIncome Tax Benefit → Gross Profit & Other Income: $7.56MGross Profit → Gross Profit & Other Income: $116.42MRevenue → Gross Profit: $116.42MRevenue → Cost of Revenue: $106.12MOther Income$59.93MIncome Tax Benefit$7.56MGross Profit$116.42MCost of Revenue$106.12MGross Profit & Other Income$183.92MNet Income$1.00MSelling, General & Admin$92.00MResearch & Development$37.73MOther Operating Expenses$25.29MInterest Expense$27.91MRevenue$222.54M

Latest period ending Dec 31, 2021 · select a line to chart its full history

Annual income statement

AMYT annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
222.54M182.61M58.12M17.09M
222.54M182.61M58.12M17.09M
106.12M119.03M38.73M6.27M
116.42M63.58M19.39M10.83M
155.01M110.04M69.87M28.87M
37.73M27.62M15.83M10.70M
92.00M76.67M35.50M17.34M
-38.59M-46.46M-50.48M-18.04M
27.91M19.57M4.76M1.84M
-7.56M-1.33M-495.00K43.00K
1.00M-104.53M-63.00M-30.49M
1.00M-104.53M-63.00M-30.49M
1.00M-104.53M-63.00M-30.49M
1.00M-104.53M-63.00M-30.49M
21.34M-86.29M-58.73M-28.60M
21.34M-86.29M-58.73M-28.60M
316.90M171.70M171.70M—